
News|Videos|January 26, 2023
Payers and Specialty Drugs
In this video, Dea Belazi, president and chief executive officer of AscellaHealth, discusses how payers will approach specialty drugs.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
The biosimilars market is projected to nearly double — here's where the growth is coming from
2
Journavx helped most patients avoid opioids after surgery, a recent study found
3
Endometriosis increases the risk of Type 2 diabetes
4
Payer Implications and Final Takeaways from the BE BOLD Trial
5






















